Charles Winter

Charles Winter

Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.

Net worth: 2 M $ as of 31/05/2026

57 year
Health Technology
Consumer Services

Profile

Charles Winter is currently Chief Technical Officer at Janux Therapeutics, Inc. since 2021.
Former positions include Vice President-Chemistry, Manufacturing & Controls at AnaptysBio, Inc. (2020–2021), Vice President-Manufacturing & Controls at Synthorx, Inc. (2020), Head-Biologics at Denali Therapeutics, Inc. (2016–2018), Vice President-Manufacturing & Technology at Eden Biologics, Inc. (2015–2016), Director-Biologics Development at Gilead Sciences, Inc. (2011–2015), and Senior Group Leader & Principal Engineer at Genentech, Inc. (1994–2011).
Education includes undergraduate studies at the University of Wisconsin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/01/2026 106,321 ( 0.18% ) 2 M $ 31/05/2026

Charles Winter active positions

CompaniesPositionStart
JANUX THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/01/2021

Former positions of Charles Winter

CompaniesPositionEnd
ANAPTYSBIO, INC. Corporate Officer/Principal 01/03/2021
SYNTHORX, INC. Corporate Officer/Principal 01/08/2020
DENALI THERAPEUTICS INC. Corporate Officer/Principal 01/06/2018
JHL BIOTECH, INC. Chief Tech/Sci/R&D Officer 01/08/2016
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/06/2015
See the detail of Charles Winter's experience

Training of Charles Winter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Charles Winter